| Year |
Citation |
Score |
| 2018 |
Alexopoulou E, Katsila T, Tolia M, Tsoukalas N, Leontsinidis M, Kyrgias G, Kouloulias V, Patrinos GP, Spyropoulou D, Kardamakis D. An Exploratory Study of Radiation Dermatitis in Breast Cancer Patients. Anticancer Research. 38: 1615-1622. PMID 29491093 DOI: 10.21873/Anticanres.12392 |
0.347 |
|
| 2018 |
Katsila T, Liontos M, Patrinos GP, Bamias A, Kardamakis D. The New Age of -omics in Urothelial Cancer - Re-wording Its Diagnosis and Treatment. Ebiomedicine. 28: 43-50. PMID 29428524 DOI: 10.1016/J.Ebiom.2018.01.044 |
0.339 |
|
| 2015 |
Giannou AD, Marazioti A, Spella M, Kanellakis NI, Apostolopoulou H, Psallidas I, Prijovich ZM, Vreka M, Zazara DE, Lilis I, Papaleonidopoulos V, Kairi CA, Patmanidi AL, Giopanou I, Spiropoulou N, ... ... Kardamakis D, et al. Mast cells mediate malignant pleural effusion formation. The Journal of Clinical Investigation. 125: 2317-34. PMID 25915587 DOI: 10.1172/Jci79840 |
0.317 |
|
| 2014 |
Spyropoulou D, Pallis AG, Leotsinidis M, Kardamakis D. Completion of radiotherapy is associated with the Vulnerable Elders Survey-13 score in elderly patients with cancer. Journal of Geriatric Oncology. 5: 20-5. PMID 24484714 DOI: 10.1016/J.Jgo.2013.08.002 |
0.324 |
|
| 2012 |
Spyropoulou D, Kardamakis D. Review of hypofractionated radiotherapy for prostate cancer. Isrn Oncology. 2012: 410892. PMID 22934194 DOI: 10.5402/2012/410892 |
0.303 |
|
| 2011 |
Vlachopoulou V, Antypas C, Delis H, Tzouras A, Salvaras N, Kardamakis D, Panayiotakis G. Peripheral doses in patients undergoing Cyberknife treatment for intracranial lesions. A single centre experience. Radiation Oncology (London, England). 6: 157. PMID 22082279 DOI: 10.1186/1748-717X-6-157 |
0.302 |
|
| 2010 |
Vassiliou V, Tselis N, Kardamakis D. Osteonecrosis of the jaws: Clinicopathologic and radiologic characteristics, preventive and therapeutic strategies Strahlentherapie Und Onkologie. 186: 367-373. PMID 20437019 DOI: 10.1007/S00066-010-2066-9 |
0.331 |
|
| 2010 |
Vassiliou V, Kalogeropoulou C, Mihael L, Tsamandas A, Petsas T, Giannopoulou E, Kardamakis D. Management of symptomatic bone metastases from breast cancer with concomitant use of external radiotherapy and ibandronate: Results of a prospective, Pilot study Breast Journal. 16: 92-94. PMID 19929886 DOI: 10.1111/J.1524-4741.2009.00867.X |
0.314 |
|
| 2009 |
Lo SS, Sahgal A, Hartsell WF, Lutz ST, Kardamakis D, van der Linden Y, Hoskin PJ. The treatment of bone metastasis with highly conformal radiation therapy: a brave new world or a costly mistake? Clinical Oncology (Royal College of Radiologists (Great Britain)). 21: 662-4. PMID 19744842 DOI: 10.1016/J.Clon.2009.08.001 |
0.309 |
|
| 2009 |
Vassiliou V, Leotsinides M, Kalogeropoulou C, Kardamakis D. Concurrent application of bisphosphonates and external beam radiotherapy in patients with metastatic bone disease from renal cancer Bju International. 104: 417-418. PMID 19614659 DOI: 10.1111/J.1464-410X.2009.08767_3.X |
0.308 |
|
| 2009 |
Chow E, Hird A, Velikova G, Johnson C, Dewolf L, Bezjak A, Wu J, Shafiq J, Sezer O, Kardamakis D, Linden Yv, Ma B, Castro M, Arnalot PF, Ahmedzai S, et al. The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire for patients with bone metastases: the EORTC QLQ-BM22. European Journal of Cancer (Oxford, England : 1990). 45: 1146-52. PMID 19097882 DOI: 10.1016/J.Ejca.2008.11.013 |
0.312 |
|
| 2007 |
Spyropoulou D, Vassiliou V, Tzelepi V, Kardari M, Tsamandas AC, Kardamakis D. Metastatic adenocarcinoma of parotid gland originating from the ampulla of vater: Case report and review of the literature Journal of Gastrointestinal Cancer. 38: 95-98. PMID 19016351 DOI: 10.1007/S12029-008-9038-7 |
0.323 |
|
| 2007 |
Vassiliou V, Kalogeropoulou C, Christopoulos C, Solomou E, Leotsinides M, Kardamakis D. Combination ibandronate and radiotherapy for the treatment of bone metastases: Clinical evaluation and radiologic assessment International Journal of Radiation Oncology Biology Physics. 67: 264-272. PMID 17084550 DOI: 10.1016/J.Ijrobp.2006.08.022 |
0.319 |
|
| 2007 |
Vomvas D, Vassiliou V, Pomoni M, Christopoulos C, Puglisi M, Katsarou C, Kardamakis D. CLC073 ORAL Combined radiotherapy and chemotherapy (vinorelbine) in locally advanced, inoperable non small-cell lung cancer (NSCLC): a pilot study Lung Cancer. 55. DOI: 10.1016/S0169-5002(07)70073-9 |
0.316 |
|
| 2006 |
Vassiliou V, Kalogeropoulou C, Christopoulos C, Solomou EK, Kardamakis D. Treating bone metastases from solid tumors with a combination of ibandronate and radiotherapy: Clinical evaluation and radiological assessment Bone. 38: 85-86. DOI: 10.1016/J.Bone.2006.01.056 |
0.328 |
|
| 2001 |
Scopa CD, Vagianos C, Kardamakis D, Kourelis TG, Kalofonos HP, Tsamandas AC. bcl-2/bax ratio as a predictive marker for therapeutic response to radiotherapy in patients with rectal cancer. Applied Immunohistochemistry & Molecular Morphology. 9: 329-334. PMID 11759059 DOI: 10.1097/00129039-200112000-00007 |
0.348 |
|
| 2001 |
Skarlos DV, Samantas E, Briassoulis E, Panoussaki E, Pavlidis N, Kalofonos HP, Kardamakis D, Tsiakopoulos E, Kosmidis P, Tsavdaridis D, Tzitzikas J, Tsekeris P, Kouvatseas G, Zamboglou N, Fountzilas G. Randomized comparison of early versus late hyperfractionated thoracic irradiation concurrently with chemotherapy in limited disease small-cell lung cancer: A randomized phase II study of the Hellenic Cooperative Oncology Group (HeCOG) Annals of Oncology. 12: 1231-1238. PMID 11697833 DOI: 10.1023/A:1012295131640 |
0.315 |
|
| 1997 |
Ginopoulos P, Spyropoulos K, Kardamakis D, Dougenis D, Onyenadum A, Gogos CH, Solomou E, Chrysanthopoulos K. Advanced non-small cell lung cancer chemotherapy: a randomized trial of two active regimens (MVP and PE) Cancer Letters. 119: 241-247. PMID 9570378 DOI: 10.1016/S0304-3835(97)00301-7 |
0.307 |
|
| 1994 |
Skarlos DV, Samantas E, Pavlidis N, Kalaitzidou E, Polyzogopoulos D, Ch K, Loucatou M, Kardamakis D, Klouvas G, Panousaki E, Makrantonakis P, Tsugranis A, Tsiakopoulos E, Fountzilas G. Intensive weekly treatment with alternating non-cross resistant combination chemotherapy and G-CSF support followed by thoracic and prophylactic cranial irradiation for good prognosis patients with small-cell lung cancer (SCLC) Lung Cancer. 11: 107. DOI: 10.1016/0169-5002(94)94179-3 |
0.333 |
|
| Show low-probability matches. |